Detalhe da pesquisa
1.
The Impact of Postoperative Renal Function Recovery after Laparoscopic and Robot-Assisted Partial Nephrectomy in Patients with Renal Cell Carcinoma.
Medicina (Kaunas)
; 58(4)2022 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454324
2.
[Paraurethral Leiomyoma in a Female Patient who Had Clinical Symptoms with Increase of Tumor Volume: A Case Report].
Hinyokika Kiyo
; 67(7): 339-342, 2021 Jul.
Artigo
em Japonês
| MEDLINE | ID: mdl-34353017
3.
[Renal Cell Carcinoma in the Left Pelvic Kidney : A Case Report].
Hinyokika Kiyo
; 67(4): 153-156, 2021 Apr.
Artigo
em Japonês
| MEDLINE | ID: mdl-34107611
4.
The Utility and Efficacy of Laparoscopic Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer at a Single Institution.
Urol Int
; 104(7-8): 573-579, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554972
5.
Impact of Robotic-Assisted Partial Nephrectomy with Single Layer versus Double Layer Renorrhaphy on Postoperative Renal Function.
Curr Oncol
; 31(5): 2758-2768, 2024 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38785490
6.
Glycocalyx analysis of bladder cancer: three-dimensional images in electron microscopy and vicia villosa lectin as a marker for invasiveness in frozen sections.
Front Cell Dev Biol
; 11: 1308879, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38269087
7.
The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study.
Cancers (Basel)
; 15(3)2023 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765903
8.
Effectiveness and Safety of Molecular-Targeted Therapy after Nivolumab Plus Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study.
Cancers (Basel)
; 14(19)2022 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230501
9.
Clinical Lymph Node Involvement as a Predictor for Cancer-Specific Survival in Patients with Penile Squamous Cell Cancer.
Curr Oncol
; 29(8): 5466-5474, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005170
10.
Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study.
Biomedicines
; 10(12)2022 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551927
11.
Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort Study.
Biomedicines
; 10(9)2022 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36140344
12.
The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma.
Biomedicines
; 10(7)2022 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35884914
13.
Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab.
J Clin Med
; 10(22)2021 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830607
14.
The utility of laparoscopic partial nephrectomy with renal function preservation, regardless of warm ischemia time, compared with laparoscopic radical nephrectomy.
Asian J Endosc Surg
; 14(3): 386-393, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33034158